Johnson & Johnson (JNJ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | JNJ | NVO | MRK | ||
| Company | Johnson & Johnson | Novo Nordisk A/S ADR | Merck & Company | ||
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | ||
| Open | 146.15 | 123.48 | 125.65 | ||
| High | 147.76 | 124.54 | 126.12 | ||
| Low | 144.54 | 122.46 | 124.89 | ||
| Last | 147.87 | 122.61 | 125.72 | ||
| Change | +2.13 | -0.14 | +0.49 | ||
| % Change | +1.46% | -0.11% | +0.39% | ||
| Volume | 5,627,430 | 4,258,808 | 6,287,977 | ||
| 20-Day Average Volume | 7,428,683 | 3,462,016 | 7,056,591 | ||
| Previous Close | 145.74 | 122.75 | 125.23 | ||
| Industry | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 151.87 | 125.95 | 127.24 | ||
| 20-Day Raw Stochastic | 27.17% | 11.41% | 26.62% | ||
| 20-Day Relative Strength | 35.28% | 45.97% | 51.26% | ||
| Weighted Alpha | -11.17 | +46.22 | +13.97 | ||
| Today's Opinion | 88% Sell | 40% Buy | 72% Buy | ||
| Previous Opinion | 88% Sell | 56% Buy | 72% Buy | ||
| Last Month's Opinion | 24% Sell | 100% Buy | 72% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.03% since 04/12/24 | -1.41% since 04/12/24 | +0.09% since 04/12/24 | ||
| Low | 143.13 on 04/18/24 | 121.79 on 04/16/24 | 124.50 on 04/18/24 | ||
| High | 149.49 on 04/15/24 | 126.05 on 04/15/24 | 127.82 on 04/15/24 | ||
| 1-Month | |||||
| %Chg | -5.59% since 03/19/24 | -6.56% since 03/19/24 | +2.99% since 03/19/24 | ||
| Low | 143.13 on 04/18/24 | 121.79 on 04/16/24 | 120.38 on 03/20/24 | ||
| High | 159.14 on 03/28/24 | 131.43 on 03/20/24 | 133.10 on 03/27/24 | ||
| 3-Month | |||||
| %Chg | -8.78% since 01/19/24 | +14.77% since 01/19/24 | +5.85% since 01/19/24 | ||
| Low | 143.13 on 04/18/24 | 103.38 on 01/23/24 | 117.27 on 01/23/24 | ||
| High | 163.58 on 01/22/24 | 138.28 on 03/07/24 | 133.10 on 03/27/24 | ||
| 6-Month | |||||
| %Chg | -3.18% since 10/19/23 | +25.70% since 10/19/23 | +25.31% since 10/19/23 | ||
| Low | 143.13 on 04/18/24 | 92.94 on 10/27/23 | 99.80 on 11/29/23 | ||
| High | 163.58 on 01/22/24 | 138.28 on 03/07/24 | 133.10 on 03/27/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 351,201,792 | 550,844,608 | 317,211,136 | ||
| Shares Outstanding, K | 2,409,783 | 4,487,532 | 2,533,028 | ||
| Annual Sales | 85,159,000,000 | 33,724,300,000 | 60,115,000,000 | ||
| Annual Net Income | 35,153,000,000 | 12,150,770,000 | 365,000,000 | ||
| Last Quarter Sales | 13,532,000,000 | 9,526,160,000 | 14,631,000,000 | ||
| Last Quarter Net Income | 4,049,000,000 | 3,175,360,000 | -1,226,000,000 | ||
| 60-Month Beta | 0.53 | 0.41 | 0.38 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.71 on 04/16/24 | 0.71 on 01/31/24 | 0.03 on 02/01/24 | ||
| Latest Earnings Date | 04/16/24 | 05/02/24 | 04/25/24 | ||
| Most Recent Dividend | 1.190 on 02/16/24 | 0.663 on 03/22/24 | 0.770 on 03/14/24 | ||
| Next Ex-Dividends Date | 05/20/24 | 03/22/24 | 03/14/24 | ||
| Ratios | |||||
| Price/Earnings ttm | 13.84 | 46.04 | 83.58 | ||